It is possible that the activation of CD8+ T cells further enhances the secretion of inflammatory cytokines and chemokines, so that immune cells are further recruited into the tumor, resulting in anti-tumor efficacy superior to VV-Control. This evidence concerns the gene CD8A and neoplasm.